Judy Lynn Chen

Judy Chen practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Judy Chen's NPI, 1801240916, was assigned on April 15, 2016. Judy Chen graduated from University of California, Geffen School of Medicine in 2016. Judy Chen holds California license A168479.

Judy Chen's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Judy Chen's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Judy Chen is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UC Davis Medical Group. Dmand AI also links Judy Chen to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Judy Chen practices, 2 sites in all. Vendor and product names are available with a free account.

Uveitis and ocular inflammatory disease is Judy Chen's primary specialty in the NPI Registry, under taxonomy code 207WX0108X. Judy Chen is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Judy Chen's licenses on file in 2 states: California and Illinois.

Dmand AI lists cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eyelid inflammation, glaucoma, glaucoma surgery and inflammation of iris among the conditions Judy Chen treats.

CMS data shows 2,294 Medicare services from Judy Chen across 13 procedure codes in 2024, for 527 Medicare patients. Medicare paid $158,053 for them.

CMS counts 527 Medicare patients who saw Judy Chen in 2024. The largest group is 65 to 74, with 222 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 27% are also on Medicaid. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Judy Chen's median patient age at 68, with 58% women.

In 2024, Judy Chen wrote 2,417 Medicare Part D claims for 412 patients. 59% of them were for generic drugs. CMS names the drug for 2,324 of them, across 30 drugs with 11 or more claims each, at $197,016 in total drug cost. In 2023, CMS named 1,609 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Judy Chen for performance year 2024, reported as part of a group. Judy Chen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 85 procedures of cataract surgery by Judy Chen, more than 72% of the clinicians it reports for that procedure.

Dmand AI links 8 papers to Judy Chen, published from 2016 to 2023. 2018 was the busiest year, with 2. The most frequent topics are Intraocular Pressure. Judy Chen has published most often in Am J Ophthalmol Case Rep. Judy Chen's most frequent co-authors are Thasarat S. Vajaranant, MD, Anthony J. Aldave, MD and Ahmad A. Aref, MD.

CMS Open Payments shows 28 general payments to Judy Chen from 8 drug and device companies from 2018 to 2024. Food and beverage make up the largest share, 100% of the total. Alcon Laboratories Inc paid the most, $638.

Judy Chen graduated from University of California, Geffen School of Medicine in 2016.

Judy Chen is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.